Exodus Point Capital Management, LP Intra Cellular Therapies, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$52.09 - $64.1 $588,512 - $724,201	-11,298 Reduced 28.27%	28,660 $1.49 Million
Q2 2023 Aug 10, 2023	BUY	$54.67 - $66.44 $2.18 Million - $2.65 Million	39,958 New	39,958 $2.53 Million
Q4 2021 Feb 11, 2022	SELL	$35.2 - $53.42 $241,436 - $366,407	-6,859 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $196,990 - $291,438	6,859 New	6,859 $256,000
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $1.96 Million - $2.71 Million	-84,027 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $1.48 Million - $2.68 Million	84,027 New	84,027 $2.16 Million
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $202,991 - $546,148	-16,490 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $29,824 - $158,116	4,108 Added 33.18%	16,490 $566,000
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $13,871 - $26,053	1,857 Added 17.64%	12,382 $92,000
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $112,091 - $150,402	10,525 New	10,525 $137,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.